Clinical Trials Information
Below you’ll find a list of both current and recently completed clinical trials
Inovio Pharmaceuticals
INO-3107 With Electroporation (EP) in Participants With HPV-6 Associated Recurrent Respiratory Papillomatosis (RRP)
Precigen Trial: Adjuvant PRGN-2012 in Adults Patients with Recurrent Respiratory Papillomatosis-Enrolling
Mass General Trial Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement
CLINICAL TRIAL – NOT YET ENROLLING
Mass General Trial Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
CLINICAL TRIAL – NO LONGER ENROLLING
NIH M7824 in People With Recurrent Respiratory Papillomatosis
COMPLETED CLINICAL TRIAL
NIDCD trial for aggressive RRP patients over 18 years old using anti-PD-L1 antibody therapy-Avelumab
COMPLETED CLINICAL TRIAL
